<p>This comprehensive overview highlights the contribution of nanomaterials in the field of biosensing, successfully amalgamating mechanical engineering and molecular biology to reimagine the detection of diseases in their earliest stages. With exemplary properties including elevated surface-to-volume ratios, heightened conductivity, and tunable optical characteristics, nanomaterials greatly enhance the sensitivity and specificity of biosensors. The current review provides a detailed analysis of metallic nanoparticles, graphene materials, and quantum dots, highlighting their imperative role in the accurate sensing of metabolic diseases, infections, and cancers. SERS, electrochemical devices, and other advanced biosensing strategies employ nanomaterials to enable ultra-sensitive detection of biomolecules and, hence rapid non-invasive diagnostic techniques. The integration of nanotechnology with liquid biopsy procedures, furthermore, serves as a novel approach to track disease progression through tumor cells and extracellular vesicles and improve the possibility of more effective and personalized therapy. The current review also clearly enunciates appreciable challenges concerning large-scale fabrication, standardization, and approval while highlighting the immense potential of nanomaterials in today’s healthcare landscape. Through the extensive analysis of nascent progress, the present research work qualifies as an indispensible reference for future queries and technological progress in biosensing. It shed light on the redefining potential of nanomaterials while highlighting their key role in reconfiguring the future of diagnostics and precision therapeutics.</p>